Delivery Order SPE2DB24D8002-SPE2DB25FJNUP
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Trulicity 3 mg/0.5 ml pens. The contract has a ceiling value of $1,633.25 and a performance period ending on May 1, 2023. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has a ceiling value of $1,873.80 and is a firm fixed price delivery order with a period of performance ending on May 22, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,650.43 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a completion date of May 23, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA as part of the ECAT Generation V Program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,337.68, is for the delivery of Trulicity 3 mg/0.5 ml pens with a completion date of April 17, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly the U.S. Armed Forces. The company holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,579.40, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This contract is not associated with a set-aside program. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,039.84 and a period of performance through October 21, 2024. Dakota Drug, Inc. is also the holder of a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract has a ceiling value of $3,287.55 and a period of performance extending through March 13, 2025. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,312.08, is for the delivery of 4,567,331,268 units of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of February 21, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,702.81 and a period of performance through March 24, 2025. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA,...